SONOSCAPE(SZ:300633) Sou Hu Cai Jing·2025-08-12 09:29Company Performance - As of August 12, 2025, the stock price of Kailing Medical (300633) closed at 34.53 yuan, an increase of 1.59% with a turnover rate of 1.99% and a trading volume of 86,300 lots, amounting to 300 million yuan [1] - The latest quarterly report shows total operating revenue of 430 million yuan, a year-on-year decrease of 10.29%, and a net profit attributable to shareholders of 8.07 million yuan, down 91.94% year-on-year [1] - The company's non-recurring net profit was 5.99 million yuan, a decrease of 93.49% year-on-year, with a current ratio of 3.527, quick ratio of 2.514, and a debt-to-asset ratio of 21.81% [1] Capital Flow - On the day of reporting, the main capital saw a net outflow of 12.41 million yuan, accounting for 4.14% of the total transaction amount [1] - Large orders experienced a net outflow of 19.99 million yuan, representing 6.67% of the transaction amount, while small orders had a net inflow of 27.30 million yuan, making up 9.11% of the transaction amount [1] Company Background - Kailing Medical, officially known as Shenzhen Kailing Biomedical Technology Co., Ltd., was established in 2002 and is located in Shenzhen, primarily engaged in technology promotion and application services [2] - The company has a registered capital of 4.327 billion yuan and a paid-in capital of 2.516 billion yuan, with Chen Zhiqiang as the legal representative [1][2] - The company has made investments in 12 enterprises, participated in 2,045 bidding projects, and holds 249 trademark registrations and 1,580 patents, along with 269 administrative licenses [2]